Acute respiratory distress syndrome

Area of Science:

• Pulmonary Medicine
• Pathophysiology
• Toxicology

Background:

• Acute Respiratory Distress Syndrome (ARDS) is linked to diverse conditions, including severe acute respiratory syndrome (SARS) from coronavirus.
• Pulmonary Edema (PE) can result from cerebral compression, leading to sympathetic activation and pulmonary circulation overload.
• Nitric Oxide (NO) plays a complex role in lung injury and pulmonary vasoconstriction.

Purpose of the Study:

• To review animal models and techniques for studying ARDS.
• To discuss the role of chemical factors, particularly nitric oxide (NO), in ARDS pathogenesis.
• To explore mechanisms of lung injury in various ARDS-associated conditions.

Main Methods:

• Review of existing literature on ARDS and pulmonary edema.
• Analysis of animal models and isolated perfused lung studies.
• Examination of chemical mediators, including nitric oxide (NO) and its synthase (NOS) inhibitors.

Main Results:

• Cerebral compression-induced PE is preventable with vasodilators, not radical scavengers.
• Exogenous and endogenous NO exacerbates lung injury in models of air embolism and ischemia/reperfusion.
• NOS inhibitors mitigate lung injury; NO levels increase during hypoxia-induced pulmonary vasoconstriction.
• Endotoxin-induced lung injury involves increased cytokines and inducible NOS, suggesting NO toxicity in endotoxin shock.
• Diverse mechanisms underlie ARDS in rare cases like Japanese B encephalitis and fat embolism.

Conclusions:

• Nitric oxide (NO) has a dual role in lung injury, potentially enhancing it in certain conditions while NOS inhibitors show therapeutic promise.
• Understanding the varied mechanisms of ARDS, including the role of NO, is crucial for clinical practice and treating conditions like SARS.
• Further research into specific ARDS etiologies, like those seen in rare patient cases, is warranted.